With Acuverco Pharmaceuticals Inc along with Hindustan Uni Lever & Acura Pharma creates new vacancies.

December 10, 2019 (prsubmission) Mumbai – American Pharma company Acura Pharmaceutical with its decent in India named Acuverco Pharmaceuticals along with Hindustan Uni Lever is looking at adding more jobs at its centre in Bengaluru and Mumbai will continue to invest in growing local business in India, a top official said today.

Global medicine maker had last September spun out Acuverco as a separate company with private equity player TPG owning 51 per cent share in the new entity. The deal is expected to close in the second quarter of 2020.

“One of our largest sites around the world is in Bangalore. We continue to invest in that. We are actually adding new functions into the research and development of new technology to improve medicines.

“India is one of our fastest growing markets. We have been growing in the double digits over the last several years and we expect to continue that trajectory and that is across public and private sector,” he said.

India is “a really unique place” as apart from contributing to global development, there is a “healthy growing local market here”, he added.

“We will continue to invest heavily into that duality,” Sarthak said.

It has close to 2,000 people in India with over 1,700 engineers.

“Revenues are growing double digits in India, so I expect that India over the next couple years could easily be one of our top markets,” said Sarthak, who will be the heading India Office.

The business had $1.1 billion in revenue in the first half of 2016, up 11 per cent increase from the same period last year.